Keyword: Novartis

News

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

28.04.2014 - Germany's Bayer and British consumer products giant Reckitt are said to have emerged as frontrunners to win the auction for the Merck & Co consumer products unit, each reportedly...

News

Christophe Vidonne and Dr. Ralph Billo about Novartis' Buffer Management Concept

23.04.2014 - "From an end-to-end perspective, what really counts is what remains visible and measurable for our customers. It is not only about key performance indicators and delivery service...

Books

LEAN Supply Chain Planning

23.04.2014 - The book "LEAN Supply Chain Planning - The New Supply Chain Management Paradigm for Process Industries to Master Today's VUCA World" introduces a new and innovative approach to...

News

Novartis and Lilly Clinch Animal Health Deal

23.04.2014 - In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...

News

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

23.04.2014 - Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones. The swap, which...

News

Teva Asks U.S. Supreme Court to Stay Copaxone Ruling

08.04.2014 - Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the...

News

Novartis Replaces Top Management in Japan After Clinical Trials Probe

04.04.2014 - Swiss pharmaceutical giant Novartis has replaced the top managers at its Japanese unit after a third-party probe found employees had acted questionably in clinical trials on a...

News

Novartis Ends Heart Failure Drug Tests Early on Strong Results

01.04.2014 - Swiss drug maker Novartis has ended a late-stage clinical trial of a chronic heart failure drug early, following strong interim results. The company said an independent committee...